Check out what we’ve been up to and where we can connect!
September 16, 2020
The operational goal is to provide experienced oversight while advancing the Partnership for Research on Vaccines and Infectious Diseases in Liberia (PREVAIL) network toward long-term, local self-sustainability – to conduct high-quality research with a focus on emergent and high-impact public health research priorities in Liberia.
August 4, 2020
FHI Clinical is pleased to announce our partnership with Tiziana Life Sciences to expedite clinical development of TZLS-501, a novel fully human anti-interleukin-6 receptor (anti-IL6R) monoclonal antibody (mAb), for the treatment of COVID-19 (SARS-CoV-2) patients.
July 23, 2020
Claudia Christian of FHI Clinical recently spoke with the editor for Outsourcing-Pharma about the clinical services that FHI Clinical is providing to the Frederick National Laboratory for Cancer Research for the ongoing ACTT adaptive study allowing investigation of putative therapeutics for the treatment of COVID-19 in hospitalized adults.
July 14, 2020
FHI Clinical Inc. announced that it has a subcontract with the Frederick National Laboratory for Cancer Research, currently operated by Leidos Biomedical Research, Inc., to provide clinical operations services for the Adaptive COVID-19 Treatment Trial (ACTT). ACTT is an adaptive study to allow investigation of putative therapeutics, for the treatment of COVID-19 in hospitalized adults.
April 21, 2021
Join us for this panel discussion in which experts in infectious diseases will discuss the effect of WHO recommendations around TPT for individuals at high risk of TB infection and increased TPT use on TB vaccine development.
March 26, 2021
Bring all your questions about things like vaccine hesitancy, equitable vaccine distribution and other issues facing the black community to “Colors of COVID-19 Barber Shop and Salon Talk.”
November 15-19, 2020
Attending the ASTMH 2020 Annual Meeting? Schedule a meeting with an FHI Clinical team member who will be in attendance at the event or stop by our booth
November 5-8, 2020
Attending WOCIP? Tafoya Hubbard and LaTonya Jones from FHI Clinical will be attending and would love to hear about your experiences in the pharmaceutical industry.
September 29, 2020
Register for this virtual plenary session at World Vaccine Congress Washington where panelists will discuss how to incorporate innovation into vaccine clinical trials, including how to apply information from the field to ongoing and future vaccine trials, use of real-world evidence for vaccine efficacy and regulatory perspectives in new development areas.
September 30, 2020
Register for this virtual roundtable at World Vaccine Congress Washington where attendees will discuss how to de-risk vaccine clinical trials in lower resource settings, both globally and within the United States, including how partnerships help achieve social impact.
FHI Clinical Headquarters
359 Blackwell Street, Suite 200
Durham, NC 27701 USA